| 4/2/2015 | CV | Market Commentary: New Trinity Biotech quiet, shares lower; overall market muted ahead of holiday weekend
|
| 1/5/2015 | CV | Annaly Capital cuts conversion price of 4% convertibles due 2015
|
| 10/20/2014 | CV | Market Commentary: Convertibles market players watching for next trend; Ares Capital, American Realty better
|
| 10/1/2014 | CV | Annaly Capital lowers conversion price of 4% convertibles due 2015
|
| 7/2/2014 | CV | Annaly Capital lowers conversion price of 4% convertibles due 2015
|
| 4/3/2014 | CV | Annaly Capital Management lowers conversion price for 4% convertibles
|
| 1/6/2014 | CV | Annaly Capital lowers conversion price of 4% convertibles due 2015
|
| 10/2/2013 | CV | Annaly Capital lowers conversion price of 4% convertibles due 2015
|
| 9/18/2013 | CV | Market Commentary: Annaly gains after Fed stands pat on bond purchases; Tower drops; Volcano extends gains
|
| 7/8/2013 | CV | Annaly Capital lowers conversion price of 4% convertibles due 2015
|
| 6/3/2013 | CV | Market Commentary: Dominion seen in gray near reoffer price; convertibles mostly quiet, better sellers seen
|
| 4/2/2013 | CV | Annaly lowers conversion price for 4% convertible notes due 2015
|
| 1/3/2013 | CV | Annaly Capital lowers conversion price on 4% convertibles due 2015
|
| 10/2/2012 | CV | Annaly Capital lowers conversion price of 4% convertibles due 2015
|
| 9/6/2012 | CVLM | Annaly Capital repurchases $280.7 million of 4% convertibles due 2015
|
| 8/23/2012 | CV | Market Commentary: Wright Medical makes 'fantastic' debut; Navistar hangs in amid lower shares; Annaly active
|
| 7/2/2012 | CV | Annaly Capital lowers conversion price on 4% convertibles due 2015
|
| 5/24/2012 | CV | Market Commentary: NetApp drops outright, expands on hedge after warning; EMC falls with NetApp, up on hedge
|
| 5/23/2012 | CV | Market Commentary: Convertibles weaken: U.S. Steel, MGM, Annaly Capital down; NetApp eyed after earnings
|
| 5/14/2012 | CV | Market Commentary: Chesapeake drops, ends off its lows; Annaly Capital steady; Chiquita finds a level at 75
|
| 5/11/2012 | CV | Market Commentary: New Medicis, Ryland upsized, trade flat to up slightly in secondary; Chesapeake pressured
|
| 5/9/2012 | CV | New Issue: Annaly's $750 million 5% three-year convertibles reoffered at 98
|
| 5/9/2012 | CV | Market Commentary: Reoffered Annaly steady; Chiquita down after earnings; Human Genome unfazed by hostile bid
|
| 5/8/2012 | CV | Annaly Capital Management to price $750 million three-year convertibles to yield 5%, up 15%
|
| 5/8/2012 | CV | Market Commentary: Thompson Creek slides; Annaly on tap; Dendreon drops outright, on hedge; Salix seen flat
|
| 4/2/2012 | CV | Annaly Capital lowers conversion price on 4% convertibles due 2015
|
| 3/27/2012 | CVLM | Annaly opts to convert all 6% series B preferreds into common stock
|
| 1/3/2012 | CV | Annaly Capital lowers conversion rate on 4% convertibles due 2015
|
| 10/4/2011 | CV | Annaly Capital cuts conversion price for 4% notes due to Q3 dividend
|
| 7/5/2011 | CV | Annaly Capital drops conversion price for 4% notes due to Q2 dividend
|
| 4/6/2011 | CV | Annaly Capital cuts conversion price for 4% notes due to Q1 dividend
|
| 1/20/2011 | CV | Market Commentary: Ares Capital, Apollo mostly flat on debuts; Apollo remarketed at 98.5; MannKind plunges
|
| 1/5/2011 | CV | Correction: Annaly lifts conversion rate on 4% convertibles to 54.1089
|
| 1/4/2011 | CV | Annaly lowers conversion price for 4% convertible notes due 2015
|
| 10/11/2010 | CV | Annaly Capital Management adjusts conversion price for 4% convertibles
|
| 7/13/2010 | CV | Market Commentary: Transocean, Microsoft continue gains as equities rally; Playboy holds steady; Annaly up
|
| 5/26/2010 | CV | Market Commentary: Convertibles better bid; Hertz, other in-the-money names improve; IG names dominate volume
|
| 5/10/2010 | CV | Market Commentary: Some convertibles bounce back, especially new issues; Transocean, ProLogis weaken further
|
| 4/7/2010 | CV | Annaly Capital Management adjusts conversion rate on 4% convertibles
|
| 3/31/2010 | CV | Market Commentary: Concur trades below par on debut; Corporate Office quiet in the gray; Kulicke and Soffa up
|
| 3/30/2010 | CV | Market Commentary: Concur draws modest enthusiasm; Theravance; Navistar, Annaly Capital better; Ford down
|
| 3/25/2010 | CV | Market Commentary: Cemex lifts on debut; SunPower launches new deal; old SunPower contracts; Best Buy adds
|
| 3/2/2010 | CV | New Issue: Annaly sells $100 million add-on of 4% convertibles due 2015, lifts issue to $600 million
|
| 3/2/2010 | CV | Market Commentary: Newmont falls; Human Genome up on earnings, health care names bid higher; Annaly sells add-on
|
| 3/1/2010 | CV | February new issue volume second lowest in 12 months, Barclays reports
|
| 2/12/2010 | CV | Market Commentary: Convertibles quiet; Annaly Capital off; Ford, Nasdaq, Avis steady; AMR adds after upgrade
|
| 2/9/2010 | CV | New Issue: Annaly Capital sells $500 million five-year convertibles at discount with 4% coupon, up 20%
|
| 2/9/2010 | CV | Market Commentary: Lincare, Alpha Natural add on positive earnings; Waste Connections expands; Annaly prices
|
| 2/8/2010 | CVHY | Annaly Capital files automatic shelf covering stock, debt, preferreds
|
| 2/8/2010 | CV | Annaly Capital to price $500 million five-year convertibles to yield 3.5%-4%, up 20%-25%
|
| 2/8/2010 | CV | Market Commentary: Airline convertibles higher in trade; Actuant active; Tyson quiet; Annaly Capital to price
|
| 5/14/2009 | CVHY | Annaly Capital files shelf covering common stock and preferred stock
|
